Litcius/Paper detail

Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose

Joseph V. Pergolizzi, Lynn R. Webster, Eugene Vortsman, Jo Ann LeQuang, Robert B. Raffa

2021Journal of Clinical Pharmacy and Therapeutics50 citationsDOIOpen Access PDF

Abstract

WHAT IS KNOWN AND OBJECTIVE: A large percentage of opioid overdose fatalities involve fentanyl or one of its legal or illegal analogs (F/FAs). Is there something about the pharmacology of these drugs that make them unusually dangerous in an overdose? COMMENT: Some of the reasons for the dangers of overdose of F/FAs is their high potency and low cost (that leads to wide distribution). But it is rarely asked if the basic pharmacology of F/FAs differ in some fundamental way from conventional opioids such as morphine and heroin. In addition to centrally mediated respiratory depression via opioid receptors, F/FAs cause rigidity in the key respiratory muscles of the chest, upper airway and diaphragm ("wooden chest syndrome," WCS) by a non-opioid mechanism. WHAT IS NEW AND CONCLUSION: WCS is an atypical pharmacology of F/FAs. Because of its rapid onset and non-opioid mechanism, WCS makes F/FA overdose particularly dangerous.

Topics & Concepts

FentanylOpioid overdoseOpioidMedicineHeroinMorphinePharmacologyDrug overdoseClinical pharmacologyAnesthesiaDrugPoison control(+)-NaloxoneReceptorMedical emergencyInternal medicineForensic Toxicology and Drug AnalysisPain Management and Opioid UsePoisoning and overdose treatments
Wooden Chest syndrome: The atypical pharmacology of fentanyl overdose | Litcius